Phenobarbital Loading in a Seizuring Cat with Hepatic Compromise
A 9-year-old female spayed domestic shorthair (4.1 kg) presents in status epilepticus after 40 minutes of cluster seizures. She has a known history of hepatic lipidosis three months ago and current labs show ALT 410 U/L, ALP 220 U/L, total bilirubin 2.1 mg/dL, and a bile acid stimulation test pending. She is already receiving midazolam by constant rate infusion at 0.3 mg/kg/h after two boluses, with only partial control. The clinician wants to start phenobarbital. The hospital has phenobarbital 130 mg/mL injectable and 15 mg and 60 mg tablets. A propofol CRI is available but the cat is not intubated.
1. Justify or refute the use of phenobarbital in this cat, addressing hepatic metabolism and the specific risks in a cat with prior hepatic lipidosis.
Read the worked answer
Justification. Phenobarbital remains a first-line agent for status epilepticus and cluster seizures in cats when benzodiazepines are insufficient. Uncontrolled seizure activity is itself injurious-excitotoxic neuronal death, hyperthermia, aspiration, and rhabdomyolysis-so the risk of untreated seizures generally outweighs the risk of a single loading dose.
Hepatic concerns. Phenobarbital is metabolized primarily by hepatic cytochrome P450 (CYP2B and CYP3A subfamilies) with renal excretion of unchanged drug and metabolites. In a cat with prior hepatic lipidosis and current enzyme elevations, clearance may be reduced, prolonging half-life and increasing the risk of sedation and ataxia. Cats are also more prone than dogs to idiosyncratic phenobarbital hepatotoxicity and to pseudolymphoma and blood dyscrasias. However, the acute priority is seizure control; the drug should be used but with heightened monitoring.
Practical points. Cats have limited hepatic glucuronidation capacity, which is one reason phenobarbital (largely oxidized, not glucuronidated) is preferred over drugs requiring glucuronidation. The prior lipidosis history warrants caution about any drug causing sedation and reduced oral intake, since anorexia is the trigger for lipidosis recurrence. Plan to transition to oral therapy as soon as seizures are controlled and the cat is eating, and monitor liver enzymes and phenobarbital levels (target 15–45 mcg/mL, with cats sometimes tolerating lower end) within 2 weeks.
2. Calculate a loading dose and describe the administration plan, including what to do if the cat remains seizuring after loading.
Read the worked answer
Loading dose calculation. A typical feline loading dose for status epilepticus is 10–20 mg/kg IV, often given as 5–10 mg/kg increments. For a 4.1 kg cat at 15 mg/kg: 4.1 × 15 = 61.5 mg, rounded to approximately 60 mg (about 0.46 mL of the 130 mg/mL solution).
Administration. Give IV slowly over 10–15 minutes (dilute in 0.9% NaCl if possible) while monitoring respiratory rate, heart rate, and sedation. Do not give the entire load as a rapid push-hypotension and respiratory depression are the main acute risks. Have intubation equipment and oxygen ready. A second 5–10 mg/kg increment can be given 20–30 minutes later if seizures persist, up to a total of roughly 20 mg/kg.
If seizures continue after loading. Escalate to a propofol CRI (0.1–0.2 mg/kg bolus titrated, then 0.1–0.25 mg/kg/min) only after intubation, since the cat is currently not intubated and propofol causes apnea. Alternatively, a levetiracetam load (20–60 mg/kg IV over 5–10 min) can be added without hepatic burden. Consider a constant rate infusion of phenobarbital if the intermittent bolus approach is inadequate, and address underlying causes (glucose, calcium, toxin screen, imaging).
Maintenance. Begin oral phenobarbital at 2–4 mg/kg q12h (starting at the lower end given hepatic concerns) once the cat is stable and eating, with a level drawn after 10–14 days.